James E. Chomas

Dr. Chomas joined KromaTiD’s board in 2021. Jim currently serves as CEO of CereHealth, a medical analytics company focused on brain health. Prior to CereHealth, Jim founded and led Surefire Medical (now TriSalus Life Sciences), an innovative oncology therapeutics and drug delivery company from initial patents through successful worldwide commercialization. Jim also served in leadership roles at Cabochon (acquired by Ulthera) and Siemens. He has authored over 40 patents in medical technology and serves as an advisor to multiple healthcare startups in the Colorado bioscience ecosystem. Jim holds a dual B.S.E in electrical and biomedical engineering from Duke University and a Ph.D. from University of Virginia.